These are exciting times at Renown Institute for Cancer. Our physicians are contributing to clinical discoveries that will set the stage for cancer treatment advancements in the years to come. We have administered over 153 trials and included more than 712 patients and participants. As Renown Institute for Cancer, our goal is to work together with our state’s Clinical Community Oncology Program (CCOP) for the betterment of the community. According to the National Comprehensive Cancer Network (NCCN).

Today, we are continuing to conduct Phase II and Phase III clinical trials sponsored by the National Cancer Institute (NCI), also private research efforts sponsored by pharmaceutical companies. We also have the capacity to conduct Phase I trials.